NorthX Biologics is a leading CDMO company specializing in the development and manufacture of vaccines, gene therapy, and other advanced therapeutics. Based in Sweden, the company offers a wide range of services across mRNA, pDNA production, protein-based therapeutics, and cell and gene therapies. Their mRNA services include process development, IVT, co-transcriptional or enzymatic capping, LNP formulation, and both research and GMP-grade production. NorthX Biologics also provides analytical support and aseptic fill/finish.
